Brazil, France and Canada come together in support of patients with Chagas disease

Experts will be linked for the next three years to improve the quality of life of people with the disease

Researchers in various fields of knowledge, spread over ten institutions from Brazil, France and Canada, will be linked for the next three years around a multidisciplinary initiative of the Instituto Oswaldo Cruz (Fiocruz), which seeks to contribute to improving the quality of life carriers of Chagas disease.

Coordinated by the head of the Laboratory of Biology of Interactions, Joseli Lannes, the initiative also has partnerships with the Institute Evandro Chagas Clinical Research (IPEC / Fiocruz) and Fiocruz Pernambuco.

Among the focuses of the project, which integrates scientific areas including immunology, pharmacology, cell biology and cardiology, is the analysis of the influence of NRF2 - gene that regulates antioxidant defenses and tolerance to tissue injury in chronic Chagas heart disease.